Phenomenex Inc. (Torrance, California, USA) has revealed it will be launching a spin-off company focusing on biological sampling called Neoteryx LLC.
Phenomenex Inc. (Torrance, California, USA) has revealed it will be launching a spin-off company focusing on biological sampling called Neoteryx LLC. Neoteryx is an independent company that aims to develop novel technologies and products for the collection, handling, and analysis of biological fluids in the pharmaceutical and clinical industries.
Neoteryx will use volumetric absorptive microsampling (VAMS) technology, developed at Phenomenex, to begin manufacturing products for the collection, handling, and analysis of biological fluids. This technology was developed over four years of internal research and development together with a co-development programme with major American and European pharmaceutical companies.
Mr. Fasha Mahjoor, Neoteryx CEO, commented: “I am excited to introduce Neoteryx, and even more so its novel technologies and products. The Mitra (RUO) Microsampling Device was officially launched at ASMS 2014 in Baltimore, Maryland [USA]. The response was overwhelmingly positive and all indications point to this device revolutionizing and simplifying how biological fluid sampling and analysis is performed”
For more information please visit www.phenomenex.com
A Review of the Latest Separation Science Research in PFAS Analysis
October 17th 2024This review aims to provide a summary of the most current analytical techniques and their applications in per- and polyfluoroalkyl substances (PFAS) research, contributing to the ongoing efforts to monitor and mitigate PFAS contamination.
Identifying PFAS in Soil Samples
October 17th 2024Jonathan Zweigle of the University Tübingen spoke with LCGC International about his work using non-targeted screening based on high-resolution mass spectrometry (HRMS) to detect PFAS in soil samples. HRMS allows scientists to determine the elemental and isotopic composition of a sample with high accuracy.